and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, clinical pharmacy specialist and co-director of endocrine disorders in pregnancy at the Cleveland Clinic Endocrinology & Metabolism Institute and a Healio | Endocrine Today Editorial Board Member, reviewed the latest data and clinical recommendations for managing diabetes during pregnancy
Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors
A high prevalence of TD has been reported among both type 1 DM (T1DM) and type 2 DM (T2DM) patients ( GLP-1 is an amino acid peptide hormone secreted by L cells of the gastrointestinal mucosa that promotes insulin secretion, suppresses glucagon secretion, and delays gastric emptying ( GLP-1 receptor agonists, a new type of antidiabetic drug for treating T2DM in recent years, with additional benefits of weight loss and blood pressure reduction ( Methods Data Sources and Searches We searched PubMed (MEDLINE), EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science from database inception to 31 October 2021 to identify eligible RCTs without restriction of language or publication period
Eight 8-ounce glasses of water a day Eat more frequent meals in smaller amounts
Understanding medication storage isn't just logisticalit directly impacts treatment outcomes
These appearances reflect our commitment to patient education, evidence-based care, and helping our community make informed healthcare decisions
